MedPath

Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)

Phase 1
Completed
Conditions
Substance-Related Disorders
Registration Number
NCT01406899
Lead Sponsor
VA Connecticut Healthcare System
Brief Summary

In this behavioral trial 80 substance abusing individuals will be randomly assigned to either treatment as usual in the substance abuse clinic of the Newington, CT VA hospital OR treatment as usual plus 8 hours of access to the 'CBT for CBT' computer program over a period of 8 weeks. Primary outcomes will be retention in treatment and reduction in substance use (percent days abstinent, confirmed by urine toxicology screens). The patients' ability to demonstrate coping skills through a computerized role-play evaluation will be a secondary outcome. A six-month follow-up will assess durability and/or delayed emergence of effects.

Detailed Description

This pilot study aims to evaluate the feasibility and effectiveness of adding a computer based training program in Cognitive Behavior Therapy ("CBT4CBT") for the treatment of addictions in a VA substance abuse outpatient clinic. Key secondary aims are to assess the impact of adding CBT4CBT to standard care on treatment attendance, engagement, retention, and to investigate if certain process measures are associated with substance use outcomes. Approximately 80 patients enrolled in the Newington Outpatient Substance Abuse Treatment Program (SATP) will be randomly assigned to either (A) treatment as usual, or (B) treatment as usual plus exposure to the CBT4CBT program.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • 18 years and older
  • Recent (within 3 months) substance use
  • meet current DSM-IV (Diagnostic and Statistical Manual-IV) criteria for substance use disorder
  • fluent in English or at least a 6th grade reading level
  • can commit to at least 8 weeks of treatment and willing to be randomized to treatment
Exclusion Criteria
  • Unstable housing situation
  • Likelihood of going to prison during the intervention portion of study
  • Recent opiate or benzodiazepine prescription

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction in substance use8 weeks

percent days abstinent, confirmed by urine toxicology screens

Secondary Outcome Measures
NameTimeMethod
Retention in treatment6 months

did patient continued to be enrolled in substance abuse treatment at follow-up

Trial Locations

Locations (1)

Connecticut VA Healthcare System

🇺🇸

Newington, Connecticut, United States

Connecticut VA Healthcare System
🇺🇸Newington, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.